Euglycemic diabetic ketoacidosis: The clinical concern of SGLT2 inhibitors
Journal of Clinical and Translational Endocrinology: Case Reports · 2016
DOI: 10.1016/j.jecr.2016.05.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Translational Endocrinology: Case Reports, 2016. Verfasst von Jamila A. Benmoussa und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Euglycemic diabetic ketoacidosis is a post market warning in patients with type 1 diabetes and type 2 diabetes treated with SGLT-2 inhibitors. We report a case of a 39-year-old obese female with presumed type 2 diabetes for seven years who presented to the emergency department with three days of nausea, vomiting, and abdominal pain. Due to previous total non-adherence with a prescribed insulin regimen, she was recently started on canagliflozin and liraglutide . The diagnosis of euDKA was missed in the initial evaluation as the blood glucose level was only 167 mg/dL. Further work up showed severe metabolic acidosis with an anion gap of 25 and positive ketones in the urine. She was treated successfully with dextrose water 5%/half normal saline and an insulin drip. As part of the work up, she tested positive for glutamic acid decarboxylase autoantibodies. Given the increasing utilization of SGLT-2 inhibitors and the fact that patients can present with near-normal glycemia, the diagnosis can be missed. Vigilance with the use of SGLT-2 inhibitors is necessary to decrease morbidity and potentially mortality particularly in patients with long-standing type 2 diabetes associated with marked β-cell insufficiency, type 1 diabetes mellitus , or latent autoimmune diabetes of adult onset.
Zitieren
APA
Benmoussa, J. A., Clarke, M., Penmetsa, A., Khine, L. Y., Leykina, L., Diaz, K., & Otterbeck, P. (2016). Euglycemic diabetic ketoacidosis: The clinical concern of SGLT2 inhibitors. Journal of Clinical and Translational Endocrinology: Case Reports. https://doi.org/10.1016/j.jecr.2016.05.002
Vancouver
Benmoussa JA, Clarke M, Penmetsa A, Khine LY, Leykina L, Diaz K, et al. Euglycemic diabetic ketoacidosis: The clinical concern of SGLT2 inhibitors. Journal of Clinical and Translational Endocrinology: Case Reports. 2016. doi:10.1016/j.jecr.2016.05.002
BibTeX
@article{Benmoussa2016,
author = {Benmoussa, Jamila A. and Clarke, Matthew and Penmetsa, Amulya and Khine, Le Yu and Leykina, Lina and Diaz, Keith and Otterbeck, Philip},
title = {Euglycemic diabetic ketoacidosis: The clinical concern of SGLT2 inhibitors},
journal = {Journal of Clinical and Translational Endocrinology: Case Reports},
year = {2016},
doi = {10.1016/j.jecr.2016.05.002}
}
EUVIMED